International Journal of Epilepsy 2016; 03(01): 42-62
DOI: 10.1016/j.ijep.2015.12.042
Abstracts
Thieme Medical and Scientific Publishers Private Ltd. 2017

Seizure outcome following primary motor cortex-sparing resective surgery for perirolandic focal cortical dysplasia

Siby Gopinath
1   Department of Neurology, Amrita Advanced Centre for Epilepsy, Amrita Institute of Medical Science, Kochi, Kerala, India
,
Arun Grace Roy
1   Department of Neurology, Amrita Advanced Centre for Epilepsy, Amrita Institute of Medical Science, Kochi, Kerala, India
,
Vinayan K Puthanveetil
1   Department of Neurology, Amrita Advanced Centre for Epilepsy, Amrita Institute of Medical Science, Kochi, Kerala, India
,
Manjit Sarma
2   Department of Nuclear Medicine & PET CT, Amrita Advanced Centre for Epilepsy, Amrita Institute of Medical Science, Kochi, Kerala, India
,
Rajesh Kannan
3   Department of Radiology, Amrita Advanced Centre for Epilepsy, Amrita Institute of Medical Science, Kochi, Kerala, India
,
Ashok Pillai
4   Department of Neurosurgery, Amrita Advanced Centre for Epilepsy, Amrita Institute of Medical Science, Kochi, Kerala, India
› Author Affiliations

Subject Editor:
Further Information

Publication History

Publication Date:
12 May 2018 (online)

Objectives: We present a case series of patients who underwent perirolandic resection for medically refractory focal epilepsy and histological evidence of focal cortical dysplasia. Our aim was to specifically evaluate the outcome of a surgical strategy intended for seizure freedom while preserving primary motor cortex function.

Materials and methods: Thirteen patients undergoing perirolandic resections for pharmacoresistant focal epilepsy between 2010 and 2015 who demonstrated histological evidence of focal cortical dysplasia were selected from a prospectively maintained database. Presurgical evaluation included video EEG telemetry and 3T MRI brain for all patients. Eight patients underwent interictal FDG PET scan. Intracranial EEG monitoring was done for 8 patients, six by conventional subdural grids and depths and two by SEEG technique. Additional techniques included extraoperative cortical stimulation mapping, intraoperative electrocorticography (ECoG), intraoperative motor cortex mapping and awake surgery in various combinations. In all cases (lesional and nonlesional), resection was intentionally limited for anatomic preservation of the primary motor cortex.

Results: Amongst the thirteen patients with age ranging 14–44 years (mean 26.8 ± 9.2) 62% of them had daily seizures. MRI abnormalities were identified in 8 patients (62%), PET showed concordant findings in 7 patients (88%). When utilized, the mean duration of intracranial EEG recordings was 8.0 + 7.2 days (range 2–23 days). All patients underwent a primary motor cortex-sparing resection of the suspected epileptogenic cortex. The mean postoperative follow up period was 23.2 months (range 8–62 months). Twelve out of 13 (92%) were seizure free (Engel 1a) outcome at the last follow-up assessment; one patient with Engel 2a outcome at 28 months. Six patients (46%) had immediate new focal neurological deficits, however all six patients had recovered completely within three months.

Conclusion: The surgical strategy of a primary motor cortex-sparing resective surgery for perirolandic FCD is associated with an excellent early seizure-freedom rate and no permanent neurological deficits. Since the ultimate goal of resective epilepsy surgery is seizure freedom with simultaneous functional preservation, similar long term outcome studies should ultimately guide the resection strategy.